RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
EKF Diagnostics Holdings Stock

EKF Diagnostics Holdings Equity 2025

EKF Diagnostics Holdings Equity

0 GBP

Ticker

EKF.L

ISIN

GB0031509804

WKN

622434

In 2025, EKF Diagnostics Holdings's equity was 0 GBP, a -100% increase from the 67.12 M GBP equity in the previous year.

EKF Diagnostics Holdings Aktienanalyse

What does EKF Diagnostics Holdings do?

EKF Diagnostics Holdings PLC is a service business that offers a wide portfolio of diagnostics, medical devices, and point-of-care systems. It is an international company that sells its products in more than 100 countries worldwide. The company has offices in North America, Europe, and Asia-Pacific. EKF Diagnostics Holdings PLC was formed in 2010 through the merger of three diagnostic companies. The history of EKF Diagnostics Holdings PLC began in 1990 with the founding of Hemocontrol. This company developed innovative devices for monitoring blood coagulation in patients with red blood cell abnormalities. In 1995, Dade Behring Diagnostics (DBD) was established as a subsidiary of Hemocontrol, specializing in the manufacture and marketing of diagnostic products. DBD quickly became a major player in the global diagnostics market and was acquired by Siemens in 2006. In 2001, Pointe Scientific was founded, a company focused on the development and production of high-quality diagnostic tests and instruments. The current business model of EKF Diagnostics Holdings PLC is based on four key areas: Diabetes Care, Point-of-Care, Central Lab, and Life Sciences. All four areas aim to develop and offer innovative solutions for better patient care. The Diabetes Care segment offers diagnostic products for monitoring diabetes. It includes HemoScan, a device for measuring hemoglobin A1C, a test that measures blood sugar levels over several months, enabling the diagnosis and monitoring of diabetes. The Point-of-Care segment offers tests and devices for performing diagnoses and treatments directly at the point of care. This includes devices for measuring blood sugar and cholesterol, as well as devices for determining hemoglobin or troponin. The Central Lab segment offers a wide range of diagnostic tests and instruments for determining blood chemistry, hematology, and immunology. This includes autoanalyzers, hemoglobin counters, and blood glucose meters. The Life Sciences segment offers a wide range of diagnostic tests, instruments, and reagents. This includes tests for cancer diagnosis and monitoring thyroid function. The company offers a variety of products to ensure optimal patient care. This includes diagnostic tests for determining infectious diseases or monitoring chronic conditions. EKF Diagnostics Holdings PLC is a company that is constantly evolving and strives to offer innovative products and solutions. The company places great emphasis on research and development to stay at the forefront of the changing market. The company has an experienced team of technicians and scientists dedicated to the development, production, and marketing of diagnostic products. EKF Diagnostics Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing EKF Diagnostics Holdings's Equity

EKF Diagnostics Holdings's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding EKF Diagnostics Holdings's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating EKF Diagnostics Holdings's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

EKF Diagnostics Holdings's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in EKF Diagnostics Holdings’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about EKF Diagnostics Holdings stock

What is the equity of EKF Diagnostics Holdings this year?

EKF Diagnostics Holdings has equity of 0 GBP this year.

What was the equity of EKF Diagnostics Holdings compared to the previous year?

The equity of EKF Diagnostics Holdings has increased/decreased by -100% decreased compared to the previous year.

What impact does a high equity have on investors of EKF Diagnostics Holdings?

A high equity is advantageous for investors of EKF Diagnostics Holdings as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of EKF Diagnostics Holdings?

A low equity can be a risk for investors of EKF Diagnostics Holdings, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of EKF Diagnostics Holdings affect the company?

An increase in equity of EKF Diagnostics Holdings can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of EKF Diagnostics Holdings affect the company?

A reduction in equity of EKF Diagnostics Holdings can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of EKF Diagnostics Holdings?

Some factors that can affect the equity of EKF Diagnostics Holdings include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of EKF Diagnostics Holdings so important for investors?

The equity of EKF Diagnostics Holdings is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can EKF Diagnostics Holdings take to change the equity?

To change equity, EKF Diagnostics Holdings can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does EKF Diagnostics Holdings pay?

Over the past 12 months, EKF Diagnostics Holdings paid a dividend of 0.01 GBP . This corresponds to a dividend yield of about 4.27 %. For the coming 12 months, EKF Diagnostics Holdings is expected to pay a dividend of 0.01 GBP.

What is the dividend yield of EKF Diagnostics Holdings?

The current dividend yield of EKF Diagnostics Holdings is 4.27 %.

When does EKF Diagnostics Holdings pay dividends?

EKF Diagnostics Holdings pays a quarterly dividend. This is distributed in the months of December, December, December, December.

How secure is the dividend of EKF Diagnostics Holdings?

EKF Diagnostics Holdings paid dividends every year for the past 3 years.

What is the dividend of EKF Diagnostics Holdings?

For the upcoming 12 months, dividends amounting to 0.01 GBP are expected. This corresponds to a dividend yield of 2.24 %.

In which sector is EKF Diagnostics Holdings located?

EKF Diagnostics Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von EKF Diagnostics Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of EKF Diagnostics Holdings from 12/1/2023 amounting to 0.012 GBP, you needed to have the stock in your portfolio before the ex-date on 11/2/2023.

When did EKF Diagnostics Holdings pay the last dividend?

The last dividend was paid out on 12/1/2023.

What was the dividend of EKF Diagnostics Holdings in the year 2024?

In the year 2024, EKF Diagnostics Holdings distributed 0.012 GBP as dividends.

In which currency does EKF Diagnostics Holdings pay out the dividend?

The dividends of EKF Diagnostics Holdings are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von EKF Diagnostics Holdings

Our stock analysis for EKF Diagnostics Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of EKF Diagnostics Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.